The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
about
Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS)Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approachRationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trialEvaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course.Acceptance of the extracare program by Beta interferon-treated patients with multiple sclerosis: results of the explore studyThe PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice.Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol.Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: a multicentre, open-label study - REGAIN.ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.'Hidden' factors influencing quality of life in patients with multiple sclerosis.Patient-reported outcomes in multiple sclerosis: a systematic comparison of available measures.Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs.Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.A short and validated multiple sclerosis-specific health-related quality of life measurement for routine medical practice.Assessing quality of life in Crohn's disease: development and validation of the Crohn's Life Impact Questionnaire (CLIQ).Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.Comparing the impact of psoriasis and atopic dermatitis on quality of life: co-calibration of the PSORIQoL and QoLIAD.Validation of a new quality of life scale related to multiple sclerosis and relapses.The impact of multiple sclerosis severity on health state utility values: Evidence from Australia.Correction: The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community.
P2860
Q21245611-1FBE7EB2-62F4-4974-8848-A3EFAE1EAAD5Q28080043-18EA371A-E65D-4FE1-A355-1B32889CFFDDQ31115496-EEB0AF22-6056-4570-BE16-346E41C7B192Q34306253-38BA503E-01B0-4D1B-98E7-BACAA41498F4Q34622205-52E02924-C50B-4582-B52A-E727EBA949AAQ34635468-3F4113FE-2B9A-4C2C-8A20-6729DA4E805BQ35100869-F3FA5F9C-20DB-4628-B585-395B896F333AQ35666531-F22CE622-F3BA-430E-A2D4-773C7AECA9FCQ36595213-CE9D39C9-6A47-4841-8045-75CB579AD632Q37197187-B0D74BFC-C1AA-4700-B2C3-5FB5D5B7788AQ37320927-9940D9BC-86B5-4143-96EC-C0B70EF90E79Q38587673-31A6D915-2552-4DB9-A138-DC63996BC9B5Q38684731-041E2C88-C36E-40F7-9DF1-B9C509C663B3Q38728373-A71F9DC3-3323-4BC1-8C72-F0431664EAC6Q43505644-F3E52AD2-DBF9-47C2-BC1B-84222FEFCAFFQ45343221-A6C9E13A-4562-49B3-9E10-2991DEC2C930Q47742192-2CF7CE9E-015B-46C3-BA79-0D285EEBCE2CQ47945489-DCF520E9-47E8-4AD3-844B-5BC443183667Q47947804-FA8B9A71-96AD-425B-AD87-AE10793F865BQ48087641-2854968B-4724-4A05-B5AB-85285F4C36B2Q48205651-ACF3E25F-D3AC-4491-9E15-9C6FD39B6E85Q51784522-4F1E7219-366F-4078-899A-6B1900F7AD27Q55715350-30DF466D-4A53-4A3E-BA01-9561734056BB
P2860
The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
@ast
The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
@en
The development of patient-reported outcome indices for multiple sclerosis
@nl
type
label
The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
@ast
The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
@en
The development of patient-reported outcome indices for multiple sclerosis
@nl
prefLabel
The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
@ast
The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
@en
The development of patient-reported outcome indices for multiple sclerosis
@nl
P2093
P2860
P356
P1476
The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
@en
P2093
P2860
P304
P356
10.1177/1352458509106513
P577
2009-06-25T00:00:00Z